CD40 and Sjogren syndrome: Interestingly, splenic MDSCs of mice in early stage of experimental Sjögren’s syndrome (10 days postimmunization) showed an immature phenotype (low expression levels of CD40, CD80, CD86 and MHC-II markers) and potent suppressive activity of T cell proliferation.